The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE
Launched by UNIVERSITY OF MIAMI · Jul 26, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device called the McMurray Enhanced Airway (MEA), which is designed to help improve oxygen delivery during a specific medical procedure called transesophageal echocardiography (TEE). The researchers want to see if using this flexible airway device is more effective than the standard nasal cannula, which is a common oxygen delivery method that fits into the nostrils.
To participate in this study, you need to be at least 18 years old and scheduled for an elective TEE procedure. It's important that you are willing to give your consent to join the trial. However, if you have certain conditions like uncontrolled acid reflux or anatomical issues with your airway, you may not be eligible. If you join the study, you can expect to be monitored closely to see how well the MEA works in providing oxygen during the procedure. This research is currently looking for volunteers, and your participation could help improve care for future patients experiencing airway obstruction.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> or = 18 years old
- • Patients willing to participate and provide an informed consent
- • Patients scheduled to undergo an elective TEE procedure.
- Exclusion Criteria:
- • Patients with history of uncontrolled gastroesophageal reflux disease
- • Patients with anatomical airway obstruction
- • Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements
About University Of Miami
The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
Patients applied
Trial Officials
Fouad G Souki, MD
Principal Investigator
University of Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported